Braveheart Bio
BRVE
18.58
-1.21
-6.11%
Braveheart Bio
US · BRVE
#2845 by market cap
Listed 2026
18.58
-1.21
-6.11%
Live - 5344 symbols - heartbeat 436s ago
· 2026-10-08 07:00
Pre-market
18.58
0.00%
After-hours
18.58
0.00%
- Market cap
- 1.67B
- P/E (TTM)i
- -3.01
- P/Bi
- -17.45
- EPSi
- -0.94
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on BRVE?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 5 analysts
Buy
Avg price target
45.25 +143.5%
Price target rangecurrent 18.58
Low40.00
Avg45.25
High48.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (9)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | Stifel | -- | BUY | 45.00 |
| 2026-09-09 | Stifel | -- | BUY | 45.00 |
| 2026-09-08 | Goldman Sachs | -- | BUY | 48.00 |
| 2026-09-06 | Stifel | -- | BUY | 45.00 |
| 2026-08-31 | TD Cowen | -- | BUY | -- |
| 2026-08-31 | Cantor Fitzgerald | -- | BUY | 40.00 |
| 2026-08-31 | Jefferies | -- | BUY | 48.00 |
| 2026-08-31 | Stifel | -- | BUY | 45.00 |
| 2026-08-31 | Goldman Sachs | -- | BUY | 48.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Quote time 2026-10-08 07:00:27 · For reference only, not investment advice and not tailored to your situation.